176 related articles for article (PubMed ID: 38020326)
1. Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium.
Zari S
Stem Cells Cloning; 2023; 16():77-89. PubMed ID: 38020326
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
El-Dawla RE; Abdelhaleem M; Abdelhamed A
Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
[TBL] [Abstract][Full Text] [Related]
3. Recent modalities in treatment of telogen effluvium: Comparative study.
Khattab FM; Rady A; Khashaba SA
Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518
[TBL] [Abstract][Full Text] [Related]
4. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment.
Lee YI; Kim J; Kim J; Park S; Lee JH
Dermatol Surg; 2020 Dec; 46(12):1698-1704. PubMed ID: 32769526
[TBL] [Abstract][Full Text] [Related]
6. Localized Telogen Effluvium Following Hair Transplantation.
Loh SH; Lew BL; Sim WY
Ann Dermatol; 2018 Apr; 30(2):214-217. PubMed ID: 29606820
[TBL] [Abstract][Full Text] [Related]
7. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
[TBL] [Abstract][Full Text] [Related]
8. Telogen effluvium after allergic contact dermatitis of the scalp.
Tosti A; Piraccini BM; van Neste DJ
Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 infection is a major cause of acute telogen effluvium.
Sharquie KE; Jabbar RI
Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
[TBL] [Abstract][Full Text] [Related]
10. Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial.
Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Pawitan JA; Liem IK; Kurniawati T; Ardelia A; Paramastri K
Stem Cell Res Ther; 2023 Aug; 14(1):210. PubMed ID: 37605227
[TBL] [Abstract][Full Text] [Related]
11. Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation.
Daly T; Daly K
J Drugs Dermatol; 2018 Nov; 17(11):1236-1240. PubMed ID: 30500148
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of QR678 Neo
Shome D; Kapoor R; Surana M; Vadera S; Shah R
J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
[TBL] [Abstract][Full Text] [Related]
13. Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell-Conditioned Medium.
Narita K; Fukuoka H; Sekiyama T; Suga H; Harii K
Dermatol Surg; 2020 Jun; 46(6):819-825. PubMed ID: 31490301
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
Turlier V; Darde MS; Loustau J; Mengeaud V
J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
[TBL] [Abstract][Full Text] [Related]
16. Telogen Effluvium: A Review of the Literature.
Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
[TBL] [Abstract][Full Text] [Related]
17. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients.
İbiş S; Aksoy Saraç G; Akdağ T
Dermatol Pract Concept; 2022 Jul; 12(3):e2022151. PubMed ID: 36159144
[TBL] [Abstract][Full Text] [Related]
19. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia.
Zufishan S; Haque Z; Nazar S; Afaq E; Aamir E; Rafique S
J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S47-S50. PubMed ID: 38385471
[TBL] [Abstract][Full Text] [Related]
20. Acute telogen effluvium triad after resolution.
Contin LA; Rocha VB
An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
